Total Laboratory Automation (TLA) and Intelligent Laboratory Platform
By integrating advanced automation, precise control, and intelligent management, it aims to revolutionize laboratory workflows. It significantly enhances efficiency and accuracy, serving as the core platform to ensure the laboratory's efficient and stable operation.

- Full-process AutomationPowered by an intelligent engine, the system integrates real-time data feedback to efficiently manage the full-process handling of samples. Through parallel computing and dynamic optimization, it enables unattended operation and enhances the level of automation.
- Precise TraceabilityThe system features built-in barcode scanning and image recognition, which automatically verify and track samples throughout the entire process. Key data is stored in real-time in a high-performance database to create detailed records. The software automatically generates compliant audit reports, ensuring data integrity and mitigating the risks of sample confusion and loss.
- Modular DesignThe system utilizes a microservices architecture, with each module operating independently to ensure flexibility and scalability. Standardized API interfaces facilitate seamless integration of new modules. Combined with containerized deployment, the system can rapidly adapt to a variety of scenarios. It operates efficiently across a wide range of throughput levels, from low to high, ensuring a strong return on investment.
- Intelligent OperationWith a high-definition touch screen and a responsive interface, the operation is intuitive and smooth. RBAC ensures security. Remote monitoring allows real-time mastery of the device and sample status. The intelligent engine analyzes data through AI algorithms and provides predictive maintenance and optimization suggestions to ensure the efficient operation of the device.
Immunoassay Platform
The immunological product platform of Wantai BioPharm covers a variety of immunological detection methods, including ELISA, colloidal gold immunochromatography, fluorescence immunoassay and other technologies. It also has the ability to develop and apply highly specific monoclonal antibodies, providing comprehensive immunological detection solutions for clinical diagnosis.

- ELISA TechnologyDevelop highly specific and highly reproducible enzyme-linked immunosorbent assay methods, which are widely used in the detection of various antigens and antibodies and are the main technical means for routine clinical detection.
- Colloidal Gold ImmunochromatographyThe rapid immunochromatography technology using colloidal gold as a marker realizes the rapid detection of samples and is widely used in point-of-care testing products.
- Immunofluorescence TechnologyThe detection technology combining fluorescence labeling and immunological reactions improves the detection sensitivity and specificity and is suitable for the detection of low-concentration biomarkers.
Biochemistry Platform
The biochemistry platform of Wantai BioPharm focuses on the development of high-performance latex immunoturbidimetric tests, deeply explores the enzymatic reaction system and chemical colorimetry technology, etc., and provides full-scenario biochemistry solutions for clinical disease diagnosis and health management.

- Latex Immunoturbidimetry TechnologyIndependently developed latex particles with uniform nanoscale particle size, diverse chemical surfaces, and low refractive index, which have good stability, do not settle, and have high sensitivity. They are standard particles measured and recommended by the international AIST and NIST.
- Enzymatic Reaction SystemDevelop a highly active and highly stable enzymatic reaction system with good substrate specificity and stable color development to ensure the accuracy and reliability of biochemistry tests.
- Chemical Colorimetry TechnologyWith fine process management and strict quality control, there is an excellent batch-to-batch difference of tests, meeting the high standards required for clinical diagnosis.
- Quality Management SystemIt has passed the ISO 9001 and ISO 13485 quality system certifications, and obtained the ISO/IEC 17025 laboratory accreditation certificate frequently issued by CNAS. It realizes the traceability of the quantity values of all products in the product line, providing a solid guarantee for product quality.
Molecular Nucleic Acid Platform
Based on nucleic acid detection technology, the molecular nucleic acid platform of Wantai BioPharm develops efficient nucleic acid extraction and multiplex PCR detection technologies, and at the same time promotes the application of innovative technologies such as isothermal amplification, providing accurate molecular diagnosis solutions for pathogen identification, gene analysis, etc.

- Nucleic Acid Extraction TechnologyDevelop efficient and convenient nucleic acid extraction and purification technologies to obtain high-quality nucleic acids from different types of samples, laying the foundation for subsequent detection.
- Multiplex PCR Detection TechnologyDevelop multiplex PCR detection methods to simultaneously detect multiple targets in a single reaction, improving detection efficiency and saving samples and time.
- Isothermal Amplification TechnologyApply isothermal nucleic acid amplification technologies such as LAMP to simplify the detection process, shorten the detection time, and meet the needs of on-site rapid detection.
Bioactive Material Platform
The bioactive material platform of Wantai BioPharm focuses on key technologies such as recombinant protein expression and purification, monoclonal antibody preparation, etc., providing high-quality biological bioactive materials for the production of diagnostic tests, vaccines, etc., and is an important support for the biomedical industry chain.

- Recombinant Protein TechnologyUsing genetic engineering methods, produce high-quality recombinant proteins in expression systems such as Escherichia coli, yeast, and mammalian cells, and apply them to the fields of diagnosis and vaccines.
- Antibody Preparation TechnologyA complete technical system for monoclonal antibody preparation, covering the entire process from antigen design, immunization, cell fusion to clone screening and large-scale culture.
- Enzymatic Test DevelopmentDevelop highly active and highly specific enzymatic tests and apply them to fields such as biochemistry analysis and molecular diagnosis to improve detection performance.
- Quality Control PlatformEstablish a strict quality control system for bioactive materials to ensure the purity, activity, and batch consistency of bioactive materials, providing a guarantee for the quality of downstream products.
Quality Control Product Platform
The quality control product platform of Wantai BioPharm is committed to developing multi-level quality control products and creating an total solution for quality control in clinical laboratories.

- Multi-level Quality Control ProductsDevelop multi-level quality control products covering both inside and outside the clinical reference range to comprehensively evaluate the accuracy and precision of the detection system at different concentrations.
- Stability TechnologyAdopt advanced freeze-drying technology and stabilizer formulations to ensure the long-term stability of quality control products, reduce batch-to-batch differences, and improve the quality control effect.
- Benchmarking with International StandardsThe research, development, and production of quality control products strictly follow international standards and are traceable to international reference materials to ensure the international comparability of test results.
- Comprehensive CoverageProvide quality control products in multiple fields such as biochemistry, immunology, and molecular diagnosis to meet the quality control needs of different detection platforms.
Vaccine Platform
With the independently innovative Escherichia coli expression system as the core, the vaccine platform of Wantai BioPharm develops various types of innovative vaccine products. It has successfully developed a variety of innovative vaccines such as the HEV vaccine and the HPV vaccine, making important contributions to the prevention of infectious diseases and the improvement of public health levels.

- Escherichia coli Expression SystemThe world's first highly efficient protein expression system, which realizes the efficient and high-quality expression of complex proteins and provides key technical support for vaccine research and development.
- VLP Vaccine TechnologyVirus-like particle (VLP) technology, which mimics the virus structure but does not contain viral nucleic acid, has high safety and good immunogenicity, and is an important direction for modern vaccine development.
- Adjuvant SystemDevelop innovative adjuvant formulations to enhance the immune response of vaccines, improve the protection effect, and extend the protection time.
- Multivalent Vaccine TechnologyThe technology for developing multivalent vaccines integrating multiple antigens, which can prevent multiple diseases with a single vaccination, improving the convenience and coverage of vaccination.
